The latest news about Lumendi

EZ¹ successfully completes Customer Evaluation phase.

Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.

Lumendi Receives 510(k) Clearance for Two New Devices

Company Achieves New Milestone with Over 4,000 Therapeutic Procedures Completed Across the U.S., Europe and Asia, Using DiLumen™ Endoluminal Interventional Platform February 16, 2023 08:00 AM Eastern Standard Time WESTPORT,… Continue reading Lumendi Receives 510(k) Clearance for Two New Devices